Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV

Diagnostic, Treatment

Approved-not yet active

18 and over

Other

KA05030-MA
KA05030, NCT00300547

Trial Description

Summary

The purpose of this study is to diagnose possible synchronous carcinomas and polyps with MR colonography in patients booked for operation because of carcinoma in the descending or sigmoid colon, where a preoperative full colonoscopy is not possible. Two days before colonography, patients ingest a 200 ml Barium sulfate solution four times a day, which will render fecal masses “invisible” on the following MR colonography. The study is primarily a feasibility study with altered operative strategy as a secondary end-point. Gold standard is colonoscopy and operation.

Eligibility Criteria

Inclusion Criteria:

Obstructing colorectal cancer

Exclusion Criteria:

Suspicion of IBD

Pacemaker

Metal in the body

Claustrophobia

Pregnancy

Trial Contact Information

Trial Lead Organizations/Sponsors

Copenhagen County Herlev University Hospital

Gentofte Hospital

Michael P Achiam, MD

Principal Investigator

Michael P Achiam, M.D.		Ph: +45 44884391
		Email: achiam1@dadlnet.dk

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00300547
Information obtained from ClinicalTrials.gov on October 20, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.